1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Abdominal Obesity Global Clinical Trials Review, H1, 2014

Abdominal Obesity Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Abdominal Obesity Global Clinical Trials Review, H1, 2014" provides data on the Abdominal Obesity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Abdominal Obesity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Abdominal Obesity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Abdominal Obesity Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Abdominal Obesity 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Abdominal Obesity 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Abdominal Obesity Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Abdominal Obesity 32
Sep 30, 2013: Lithera Reports Positive Clinical Study Results From Its Phase 2b RESET Trial for LIPO-202, a Novel Treatment for Abdominal Body Contouring 32
May 07, 2013: Aileron Therapeutics Successfully Completes Stapled Peptide Clinical Trial 32
Mar 12, 2013: Lithera Initiates Phase IIb Clinical Trial Of LIPO-202 Targeting Aesthetic Reduction Of Subcutaneous Abdominal Fat 33
May 10, 2012: Theratechnologies Initiates Preclinical Safety Program For New GRF Peptide, TH1173 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Genfit SA 34
Clinical Trial Overview of Genfit SA 34
Lithera, Inc. 35
Clinical Trial Overview of Lithera, Inc. 35
AstraZeneca PLC 36
Clinical Trial Overview of AstraZeneca PLC 36
Sanofi 37
Clinical Trial Overview of Sanofi 37
Novartis AG 38
Clinical Trial Overview of Novartis AG 38
Hanmi Science Co., Ltd. 39
Clinical Trial Overview of Hanmi Science Co., Ltd. 39
Parry Nutraceuticals 40
Clinical Trial Overview of Parry Nutraceuticals 40
Kythera Biopharmaceuticals, Inc. 41
Clinical Trial Overview of Kythera Biopharmaceuticals, Inc. 41
Johnson and Johnson 42
Clinical Trial Overview of Johnson and Johnson 42
Clinical Trial Overview of Top Institutes / Government 43
Queen's University 43
Clinical Trial Overview of Queen's University 43
Massachusetts General Hospital 44
Clinical Trial Overview of Massachusetts General Hospital 44
University of Pittsburgh 45
Clinical Trial Overview of University of Pittsburgh 45
Wake Forest University 46
Clinical Trial Overview of Wake Forest University 46
Baker IDI Heart and Diabetes Institute 47
Clinical Trial Overview of Baker IDI Heart and Diabetes Institute 47
Rush University Medical Center 48
Clinical Trial Overview of Rush University Medical Center 48
UMC Utrecht Holding BV 49
Clinical Trial Overview of UMC Utrecht Holding BV 49
Southeast University 50
Clinical Trial Overview of Southeast University 50
Washington University School of Medicine 51
Clinical Trial Overview of Washington University School of Medicine 51
Maastricht University Medical Center 52
Clinical Trial Overview of Maastricht University Medical Center 52
Five Key Clinical Profiles 53
Appendix 105
Abbreviations 105
Definitions 105
Research Methodology 106
Secondary Research 106
About GlobalData 107
Contact Us 107
Disclaimer 107
Source 107

List of Tables
Abdominal Obesity Therapeutics, Global, Clinical Trials by Region, 2014* 7
Abdominal Obesity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Abdominal Obesity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Abdominal Obesity Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Abdominal Obesity Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Abdominal Obesity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Abdominal Obesity Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Abdominal Obesity Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Abdominal Obesity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Abdominal Obesity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Abdominal Obesity Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Abdominal Obesity Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Abdominal Obesity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Abdominal Obesity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Abdominal Obesity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Abdominal Obesity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Abdominal Obesity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2014* 34
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Lithera, Inc., 2014* 35
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 36
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 37
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 38
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Hanmi Science Co., Ltd., 2014* 39
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Parry Nutraceuticals, 2014* 40
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Kythera Biopharmaceuticals, Inc., 2014* 41
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 42
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2014* 43
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 44
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 45
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014* 46
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Baker IDI Heart and Diabetes Institute, 2014* 47
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2014* 48
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014* 49
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeast University, 2014* 50
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 51
Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014* 52

List of Figures
Abdominal Obesity Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Abdominal Obesity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Abdominal Obesity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Abdominal Obesity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Abdominal Obesity Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Abdominal Obesity Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Abdominal Obesity Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Abdominal Obesity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Abdominal Obesity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Abdominal Obesity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Abdominal Obesity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Abdominal Obesity Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Abdominal Obesity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Abdominal Obesity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 106

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.